Controlled Drugs and Substances Act

Controlled Drugs and Substances Act
Short title	Controlled Drugs and Substances Act
Citation	S.C. 1996, c. 19
Enacted by	Parliament of Canada
Royal assent	June 20, 1996
Status	in force

Controlled Drugs and Substances Act. The primary federal statute governing drug policy in Canada, it consolidates and repeals earlier legislation like the Narcotic Control Act and parts of the Food and Drugs Act. Enacted in 1996, the law establishes a framework for controlling substances deemed to pose a risk to public health or safety, outlining prohibitions, penalties, and regulatory powers. It serves as the cornerstone for Canada's approach to illicit drugs, psychoactive substances, and the legal regulation of certain activities.

Overview and legislative history

The development of this legislation was influenced by Canada's obligations under international treaties, including the Single Convention on Narcotic Drugs and the Convention on Psychotropic Substances. It replaced a patchwork of older laws, responding to evolving societal concerns and the proliferation of new synthetic drugs. Key figures in its passage included members of the Jean Chrétien ministry and the Department of Justice (Canada). The act has been significantly amended over time, most notably by the Cannabis Act in 2018, which removed cannabis from its schedules, and by subsequent reforms addressing the opioid crisis.

Schedules of controlled substances

The act organizes controlled substances into eight schedules, with Schedule I containing the most severely restricted drugs like heroin, cocaine, and fentanyl. Schedule II pertains solely to cannabis and its derivatives, though it was rendered largely inactive by the Cannabis Act. Schedules III and IV include substances such as barbiturates, benzodiazepines, and anabolic steroids. The legislation grants the Governor in Council the authority, on the recommendation of the Minister of Health (Canada), to add or remove substances based on advice from bodies like the Expert Advisory Committee on Drugs.

Offences and penalties

The act defines several key offences, including possession, trafficking, possession for the purpose of trafficking, importing and exporting, and production. Penalties vary dramatically based on the substance's schedule, the amount involved, and the presence of aggravating factors like involvement of organized crime or proximity to schools. Convictions for Schedule I or II substances can lead to life imprisonment. The act also includes provisions for drug paraphernalia and outlines specific offences related to methamphetamine and ecstasy production. Alternative measures, such as diversion programs and treatment courts, exist for certain possession offences.

Enforcement and administration

Primary enforcement authority rests with the Royal Canadian Mounted Police, Canada Border Services Agency, and provincial police forces. The Public Prosecution Service of Canada is responsible for prosecuting offences. The Minister of Health (Canada) administers the regulatory aspects, including granting exemptions for medical purposes and scientific research. Agencies like the Canadian Institutes of Health Research may be involved in sanctioned studies. The act also provides for the seizure and forfeiture of property and assets derived from illicit activities.

Legal challenges and amendments

The act has faced numerous constitutional challenges under the Canadian Charter of Rights and Freedoms. Notable cases include rulings on the validity of search powers and the legality of certain mandatory minimum sentences. Major amendments include the Safe Streets and Communities Act in 2012, which introduced stricter penalties, and the Good Samaritan Drug Overdose Act in 2017, providing limited immunity for those seeking emergency assistance. Ongoing debates center on decriminalization, as seen in pilot projects in British Columbia, and reforms to address substance use as a public health issue.

International context and treaties

The legislation is designed to fulfill Canada's obligations under United Nations drug control treaties, including the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. Canada coordinates with international bodies like the International Narcotics Control Board and collaborates with allies such as the United States Drug Enforcement Administration and the European Monitoring Centre for Drugs and Drug Addiction. The act's provisions on import and export are directly tied to these international commitments.

Category:Canadian federal legislation Category:Drug control law